Skip to the page

Data / New clinical trials / Atherosclerosis

Atherosclerosis trials: 139 new since Nov 2024

The full list. New Atherosclerosis clinical trials: 139 rows for $6.95, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 7 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/atherosclerosis, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

139 clinical studies in atherosclerosis were first posted on ClinicalTrials.gov from November 18, 2024 to November 5, 2026; 36 have an industry sponsor and 98 are recruiting or about to. The newest, NCT07920133, was posted on November 5, 2026: Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI... (Sir Run Run Shaw Hospital).

The request: Every new Atherosclerosis clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

  • 139New trials
  • 36Industry sponsored
  • 98Recruiting or not yet
  • November 5, 2026Latest posted

Newest trials

The newest 100 of 139, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First postedNCT IDTitleSponsorPhaseStatusConditionsEnrollmentCountriesSource
November 5, 2026NCT07920133Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)Sir Run Run Shaw HospitalNot applicableNot yet recruitingCoronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Residual Inflammatory Risk1,768Chinaclinicaltrials.gov
November 4, 2026NCT07916883PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)Washington University School of MedicineObservationalNot yet recruitingCarotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis30United Statesclinicaltrials.gov
November 4, 2026NCT07914777EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of...NYU Langone HealthNot applicableNot yet recruitingAtherosclerotic Cardiovascular Disease7,501United Statesclinicaltrials.gov
November 3, 2026NCT07913919Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus StudyUniversity of CambridgeNot applicableRecruitingSystemic Lupus Erythematosus, Atherosclerosis Generalized15United Kingdomclinicaltrials.gov
October 30, 2026NCT07906132A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic...SanofiObservationalCompletedAtherosclerotic Cardiovascular Disease93,000Italyclinicaltrials.gov
October 29, 2026NCT07905534A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic...SanofiObservationalActive not recruitingAtherosclerotic Cardiovascular Disease18,000Spainclinicaltrials.gov
October 29, 2026NCT07905508A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic...SanofiObservationalCompletedAtherosclerotic Cardiovascular Disease180,000Netherlandsclinicaltrials.gov
October 16, 2026NCT07877324Vascular Inflammation in Atherosclerosis - Whole Body Molecular PET/CT Imaging Using Folate Receptor βTurku University HospitalNot applicableRecruitingAtheroscleroses, Inflammation90Finlandclinicaltrials.gov
October 8, 2026NCT07865884Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy SpecimensSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalObservationalNot yet recruitingBreast Cancer, Vascular Calcification, Coronary Artery Calcification, Atherosclerosis Cardiovascular Disease100clinicaltrials.gov
October 2, 2026NCT07856264PCSK9 Inhibitors in Hyperlipidemia and AtherosclerosisFundación Santa Fe de BogotaObservationalNot yet recruitingHyperlipidemia, Atherosclerotic Cardiovascular Disease (ASCVD)100clinicaltrials.gov
October 2, 2026NCT07856199Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery DiseaseHospital Central MilitarNot applicableRecruitingCoronary Artery Disease, Erectile Dysfunction, Atherosclerosis60Mexicoclinicaltrials.gov
September 30, 2026NCT07849127wCAR-Austria: A Women-Specific Score to Assess Cardiovascular Risk in Women Aged 40 to 65Women's Heart AustriaNot applicableNot yet recruitingCardiovascular Diseases (CVD), Coronary Artery Disease, Atheroscleroses800Austriaclinicaltrials.gov
September 25, 2026NCT07840950Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World StudyXiangya Hospital of Central South UniversityNot applicableNot yet recruitingCarotid Artery Plaques, Atherosclerosis, Ischemic Stroke200clinicaltrials.gov
September 24, 2026NCT07839936A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseVerve Therapeutics, Inc.Phase 2Not yet recruitingAtherosclerosis, Cardiovascular Disease, Hypercholesterolemia175United Statesclinicaltrials.gov
September 24, 2026NCT07839741LDL Cholesterol Reduction Following Ezetimibe InitiationUniversidade do PortoPhase 4RecruitingAtherosclerotic Cardiovascular Disease (ASCVD), Cardiovascular Risk, LDL Cholesterol100Portugalclinicaltrials.gov
September 24, 2026NCT07837934Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 DiabetesTan Tock Seng HospitalPhase 2RecruitingType 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases300Singaporeclinicaltrials.gov
September 21, 2026NCT07832175AI-CCTA for Predicting Cardiovascular Events in CADNanjing First Hospital, Nanjing Medical UniversityObservationalActive not recruitingCoronary Artery Disease, Atherosclerotic Cardiovascular Disease3,000Chinaclinicaltrials.gov
September 2, 2026NCT07800481PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study)Washington University School of MedicineEarly phase 1RecruitingHealthy Adult, Healthy8United Statesclinicaltrials.gov
September 2, 2026NCT07800351Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid ArthritisTanta UniversityPhase 3Not yet recruitingRheumatoid Arthritis (RA, Atherosclerosis46Egyptclinicaltrials.gov
August 25, 2026NCT07783802A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventEli Lilly and CompanyPhase 2RecruitingAtherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic120Argentina, Japan, Puerto Rico, United Statesclinicaltrials.gov
August 21, 2026NCT07780552CHIP in Health and DiseaseVASCage GmbHObservationalNot yet recruitingClonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance...120Austriaclinicaltrials.gov
August 20, 2026NCT07775664Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD RiskPutuo Hospital, Shanghai University of Traditional Chinese MedicineNot applicableActive not recruitingType 2 Diabetes Mellitus, Endothelial Dysfunction, Cardiovascular Risk90Chinaclinicaltrials.gov
August 19, 2026NCT07772466Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media ThicknessAssiut UniversityObservationalNot yet recruitingAtheroscleroses, Rheumatoid Arthritis (RA70clinicaltrials.gov
August 14, 2026NCT07765797Development and Validation of a Scale of Propensity for Change in Chronic Disease PreventionUniversity Hospital, ToulouseObservationalNot yet recruitingAtheroscleroses, Geriatric290Franceclinicaltrials.gov
August 3, 2026NCT07743021Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding DataCenter for Molecular Fingerprinting Research Nonprofit LLCObservationalRecruitingNon-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic...15,000Hungaryclinicaltrials.gov
July 27, 2026NCT07729475A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of...Shenzhen Salubris Pharmaceuticals Co., Ltd.Phase 2Not yet recruitingElevated Lipoprotein(a)120Chinaclinicaltrials.gov
July 22, 2026NCT07719894Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 DiabetesSeoul National University Bundang HospitalPhase 4RecruitingType 2 Diabetes Mellitus (T2DM), Atherosclerosis1,200South Koreaclinicaltrials.gov
July 15, 2026NCT07704918Aggressive Lipid Lowering Therapy in ICI-Treated MelanomaUniversity of Colorado, DenverNot applicableRecruitingMelanoma40United Statesclinicaltrials.gov
July 15, 2026NCT07704190Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular DiseasePeking University Third HospitalPhase 4Not yet recruitingCardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery...100clinicaltrials.gov
July 15, 2026NCT07704164Colchicine to Reduce Coronary Artery Inflammation in People With HIVInstituto de Investigación Hospital Universitario La PazPhase 2RecruitingHIV Infection, Cardiovascular Diseases (CVD)90Spainclinicaltrials.gov
July 9, 2026NCT07693712Senescence in Myocardial InfarctionSouth Tees Hospitals NHS Foundation TrustObservationalTerminatedCardiovascular Diseases, Coronary Artery Disease, Aging, Atherosclerosis, Myocardial Infarction, Inflammation, Heart...22United Kingdomclinicaltrials.gov
July 7, 2026NCT07686991Cardiovascular Risk in Patients With Takayasu Arteritis: A Nationwide Population-Based Cohort StudyGroupe français d'étude des Maladies Inflammatoires de loeilObservationalCompletedTakayasu Arteritis, Cardiovascular Diseases8,275Franceclinicaltrials.gov
June 30, 2026NCT07675928Qatar Cardiometabolic CohortWeill Cornell Medical College in QatarObservationalNot yet recruitingCardiometabolic Diseases3,000Qatarclinicaltrials.gov
June 24, 2026NCT07665034Isometric Resistance Exercise on Accelerated Atherosclerosis in HypertensionChinese University of Hong KongNot applicableRecruitingAtherosclerosis Cardiovascular Disease200Hong Kongclinicaltrials.gov
June 4, 2026NCT07625488Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)Radboud University Medical CenterObservationalEnrolling by invitationCoronary Artery Disease, Atherosclerosis250Netherlandsclinicaltrials.gov
June 2, 2026NCT07619820A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)CSL BehringPhase 1RecruitingEnd Stage Kidney Disease (ESKD)24Chinaclinicaltrials.gov
May 29, 2026NCT07615296Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and...Beijing Anzhen HospitalNot applicableNot yet recruitingAtherosclerotic Cardiovascular Disease (ASCVD)6,000Chinaclinicaltrials.gov
May 29, 2026NCT07615166Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine...SanofiObservationalCompletedAtherosclerotic Cardiovascular Disease996United Statesclinicaltrials.gov
May 29, 2026NCT07614230SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in DiabetesJunjie YangPhase 4RecruitingType 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis144Chinaclinicaltrials.gov
May 29, 2026NCT07613294A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High...Eli Lilly and CompanyPhase 3RecruitingAtherosclerosis, Cardiovascular Diseases, Lipoprotein(a)252Australia, Czechia, Hungary, Netherlands, Spain, United Kingdom, United Statesclinicaltrials.gov
May 28, 2026NCT07611747Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)Instituto de Investigación Marqués de ValdecillaPhase 4RecruitingRheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular...1,944Spainclinicaltrials.gov
May 18, 2026NCT07594392Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFESt. Jude Children's Research HospitalObservationalRecruitingAtherosclerotic Cardiovascular Disease650United Statesclinicaltrials.gov
May 12, 2026NCT07581808Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary PreventionUniversity Medical Centre LjubljanaPhase 4RecruitingHypercholesterolemia, Atherosclerotic Cardiovascular Disease (ASCVD)60Sloveniaclinicaltrials.gov
May 7, 2026NCT07573319The SCAPIS-Snus StudyKarolinska InstitutetObservationalActive not recruitingNicotine, Mental Health, Cardiovascular (CV) Risk, Metabolic Abnormalities30,154Swedenclinicaltrials.gov
April 30, 2026NCT07558239Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk FactorsMinia UniversityObservationalNot yet recruitingDialysis Patients, Hypertension, Atherosclerosis100clinicaltrials.gov
April 29, 2026NCT07556887Clinical Impact of Using IMPROVE to Select Patients for Carotid RevascularisationMaastricht University Medical CenterNot applicableRecruitingCarotid Artery Stenosis Symptomatic, Ischemic Cerebral Infarction, Stroke Ischemic, Atheroscleroses, Stroke (CVA) or...613Netherlandsclinicaltrials.gov
April 24, 2026NCT07551492A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular DiseaseFujian Shengdi Pharmaceutical Co., Ltd.Phase 3RecruitingAtherosclerotic Cardiovascular Disease9,262Chinaclinicaltrials.gov
April 22, 2026NCT07545408Subclinical Atherosclerosis in Juvenile Systemic Lupus ErythematosusAssiut UniversityObservationalNot yet recruitingAtherosclerosis70clinicaltrials.gov
April 22, 2026NCT07543731A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and AlirocumabNovartis PharmaceuticalsObservationalRecruitingCardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia, Familial5,995Switzerlandclinicaltrials.gov
April 21, 2026NCT07542860Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease PatientsPeking University First HospitalObservationalRecruitingAtherosclerotic Cardiovascular Disease (ASCVD), Secondary Prevention, Cardiovascular Diseases5,448Chinaclinicaltrials.gov
April 13, 2026NCT07524101Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVDYonsei UniversityNot applicableRecruitingRenal Insufficiency, Atherosclerosis, Dyslipidemia, Hypercholesterolemia, Cardiovascular Diseases1,952South Koreaclinicaltrials.gov
April 9, 2026NCT07521007A Phase 2b Clinical Trial of YN001 in Adults With Coronary AtherosclerosisBeijing Inno Medicine Co., Ltd.Phase 2RecruitingAtherosclerosis, Coronary Artery Disease456Australia, Canada, China, United Statesclinicaltrials.gov
April 9, 2026NCT07520643MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular SignalingFondazione Policlinico Universitario Agostino Gemelli IRCCSObservationalNot yet recruitingSubclinical Atherosclerotic Cardiovascular Disease, Neurocognitive Decline1,000Italyclinicaltrials.gov
March 25, 2026NCT07493603A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart DiseaseXia LiangPhase 1/2RecruitingCoronary Heart Disease, Coronary Artery Disease, Atheroscleroses30Chinaclinicaltrials.gov
March 23, 2026NCT07487363TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDHudson BiotechPhase 1/2RecruitingAtherosclerotic Cardiovascular Diseases, Endothelial Dysfunction80Chinaclinicaltrials.gov
March 16, 2026NCT07474233Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic HealthLiverpool John Moores UniversityObservationalNot yet recruitingAtherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction90United Kingdomclinicaltrials.gov
March 10, 2026NCT07462871Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic HealthLiverpool John Moores UniversityNot applicableNot yet recruitingAtherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia30United Kingdomclinicaltrials.gov
March 10, 2026NCT07460960TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in MenLomonosov Moscow State University Medical Research and Educational CenterPhase 2RecruitingErectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen...150Russiaclinicaltrials.gov
March 4, 2026NCT07448038A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation...Genentech, Inc.Phase 2RecruitingAtherosclerosis162Canada, United Statesclinicaltrials.gov
March 3, 2026NCT07447648Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque...Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)ObservationalRecruitingHomozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography52France, Italy, Netherlands, Turkey (Türkiye)clinicaltrials.gov
February 23, 2026NCT07428473A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)Monash UniversityPhase 1RecruitingElevated LDL-C and High Cholesterol64Australia, New Zealandclinicaltrials.gov
February 23, 2026NCT07427472"Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"Assistance Publique - Hôpitaux de ParisNot applicableRecruitingHeterozygous Familial Hypercholesterolemia (HeFH)300Franceclinicaltrials.gov
February 19, 2026NCT07422051Erythrodiol in Pomace Olive Oil as a Protective Agent Against AtherosclerosisSpanish National Research CouncilPhase 2Not yet recruitingAtherosclerosis Cardiovascular Disease22Spainclinicaltrials.gov
February 18, 2026NCT07416344A Coronary Computed Tomography Angiography-guided Intervention for High Risk Cardiovascular Disease Population in Rural ChinaHarbin Medical UniversityNot applicableEnrolling by invitationCoronary Artery Disease14,980Chinaclinicaltrials.gov
February 17, 2026NCT07412457Guideline Adherence in Dyslipidemia With Clinical Decision SupportI.M. Sechenov First Moscow State Medical UniversityObservationalNot yet recruitingDyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries, Cardiovascular Risk, Subclinical...500Russiaclinicaltrials.gov
February 9, 2026NCT07396025Effectiveness of Surgical and Diagnostic Methods in Cerebral Vascular Occlusive DiseaseNational Centre for Neurosurgery, Republic of KazakhstanNot applicableEnrolling by invitationCarotid Artery Occlusion60Kazakhstanclinicaltrials.gov
February 6, 2026NCT07394400Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.Milagros Rocha BarajasObservationalNot yet recruitingTransgender Individuals94Spainclinicaltrials.gov
February 3, 2026NCT07384910Assessment of GARP Expression in Acute and Chronic Coronary SyndromeUniversité Catholique de LouvainNot applicableNot yet recruitingAtheroma; Heart600Belgiumclinicaltrials.gov
February 2, 2026NCT07380828CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF)Russian Scientific Medical Society of TherapistsObservationalNot yet recruitingHeart Failure, Cardio-renal-metabolic Syndrome3,000clinicaltrials.gov
January 23, 2026NCT07364058Assessment of Platelet-derived GARP in Atherosclerotic DiseaseUniversité Catholique de LouvainObservationalNot yet recruitingAtheroma; Carotid Artery, Atheromatosis200Belgiumclinicaltrials.gov
January 21, 2026NCT07355894Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)Stanford UniversityNot applicableNot yet recruitingAtherosclerotic Cardiovascular Disease (ASCVD), Coronary Artery Calcification120,000United Statesclinicaltrials.gov
January 20, 2026NCT07352111High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial InfarctionI.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioNot applicableRecruitingCoronary Artery Diease200Italyclinicaltrials.gov
January 12, 2026NCT07334834Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic...Colorado Prevention CenterNot applicableRecruitingHyperlipidemia100United Statesclinicaltrials.gov
January 5, 2026NCT07315997The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) StudyBrigham and Women's HospitalObservationalRecruitingRheumatoid Arthritis (RA, Atherosclerotic Cardiovascular Disease (ASCVD)120United Statesclinicaltrials.gov
December 31, 2025NCT07312383Skin Microcirculation in Patients With Lower Limb AtherosclerosisODI Medical ASNot applicableRecruitingPercutaneous Transluminal Angioplasty, Atherosclerosis of Arteries of the Extremities, Unspecified30Norwayclinicaltrials.gov
December 30, 2025NCT07311330Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile DysfunctionBeijing Inno Medicine Co., Ltd.Phase 2RecruitingAtherosclerotic Cardiovascular Disease (ASCVD), Erectile Dysfunction40Chinaclinicaltrials.gov
December 24, 2025NCT07301489Akershus Cardiac Examination (ACE) 5 StudyUniversity Hospital, AkershusNot applicableRecruitingHeavy Smokers, Lung Cancer Screening, Cardiovascular Risk Profile, Cardiovascular Disease Prevention1,000Norwayclinicaltrials.gov
December 22, 2025NCT07296965Oral Microbiome in Carotid AtherosclerosisSemmelweis University Heart and Vascular CenterObservationalRecruitingAtherosclerosis Cardiovascular Disease, Atherosclerosis of Artery, Carotid Artery Plaque, Periodontitis, Carotid Artery...200Hungaryclinicaltrials.gov
December 19, 2025NCT07295366Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled TrialThe Affiliated Hospital of Xuzhou Medical UniversityPhase 4CompletedAcute Stroke60Chinaclinicaltrials.gov
December 17, 2025NCT07289919Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower OilsUniversity of Sao PauloNot applicableActive not recruitingCardiovascular (CV) Risk, Atheroscleroses, Inflamation, Omega 3 Fatty Acids, Supplement15Brazilclinicaltrials.gov
December 11, 2025NCT07276282Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial InfarctionECRI bvPhase 3RecruitingCoronary Artery Disease, Acute Myocardial Infarction (AMI), Coronary Atherosclerosis of Native Coronary Artery332Switzerlandclinicaltrials.gov
December 5, 2025NCT07266220Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients.Abdallah Ali MohammedObservationalNot yet recruitingDiabetes Mellitus, Type 2, Chronic Kidney Disease, Atherosclerosis96clinicaltrials.gov
December 4, 2025NCT07263113Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk...Nantes University HospitalNot applicableRecruitingPeriodontis, Atherosclerosis Cardiovascular Disease206Franceclinicaltrials.gov
November 19, 2025NCT07235046A Study of DII235 in Adults With Elevated Lipoprotein(a)Novartis PharmaceuticalsPhase 2Active not recruitingLipoprotein Disorder234China, Germany, Japan, United Statesclinicaltrials.gov
November 10, 2025NCT07226193Detecting Peripheral Artery Disease With the PulseUniversity of NebraskaNot applicableRecruitingPeripheral Artery Disease (PAD)60United Statesclinicaltrials.gov
October 23, 2025NCT07220304CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)Corazon Medical PCNot applicableNot yet recruitingCoronary Artery Disease, Atherosclerosis, Cardiovascular Inflammation15,000United Statesclinicaltrials.gov
October 6, 2025NCT07208331Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk ManagementAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)ObservationalRecruitingAtherosclerotic Cardiovascular Disease (ASCVD), Hypertension, Dyslipidemia750Netherlandsclinicaltrials.gov
October 2, 2025NCT07203677Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)Brigham and Women's HospitalObservationalCompletedType2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease49,065United Statesclinicaltrials.gov
October 1, 2025NCT07200804Relationship Between Serum Vitamin D and Atherosclerosis in Hemodialysis PatientsAin Shams UniversityObservationalCompletedSerum, Vitamin D, Atherosclerosis, Hemodialysis90Egyptclinicaltrials.gov
September 29, 2025NCT07196280Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK...Chinese PLA General HospitalObservationalCompletedAtherosclerotic Cardiovascular Disease (ASCVD), Benign Prostatic Hypertrophy (BPH)10,000clinicaltrials.gov
September 17, 2025NCT07178015A Cohort Study on Cardiovascular and Cerebrovascular OutcomesSun Yat-sen UniversityObservationalEnrolling by invitationStroke, Atheroscleroses855Chinaclinicaltrials.gov
September 12, 2025NCT07169682Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With PsoriasisNational and Kapodistrian University of AthensObservationalCompletedPsoriasis, Cardiovascular Disease, Atherosclerosis66Greececlinicaltrials.gov
September 8, 2025NCT07160829Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure ManagementNovo Nordisk A/SObservationalCompletedAtherosclerotic Cardiovascular Disease, Heart Failure, Chronic Kidney Disease608Australia, India, South Korea, Thailandclinicaltrials.gov
September 5, 2025NCT07157774Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)Eli Lilly and CompanyPhase 3RecruitingElevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)10,450Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia...clinicaltrials.gov
August 26, 2025NCT07141914A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real...Novo Nordisk A/SObservationalCompletedOverweight, Obesity, Heart Failure (HF), Atherosclerotic Cardiovascular Disease (ASCVD), Primary Prevention285,327United Statesclinicaltrials.gov
August 21, 2025NCT07134166Cardiac Imaging in Systemic Disorders: the ORACLES RegistryAssistance Publique - Hôpitaux de ParisObservationalNot yet recruitingLupus1,500clinicaltrials.gov
August 14, 2025NCT07123610Mediterranean Diet Education in Shift Nurses: Effects on Sleep, Activity, and Health ParametersBahçeşehir UniversityNot applicableCompletedCardiovascular Diseases, Obesity Prevention, Atheroscleroses, Hypertension, Type 2 Diabetes Mellitus (T2DM)...130Turkey (Türkiye)clinicaltrials.gov
August 13, 2025NCT07121010How Animal and Plant Protein Shakes Change the Body's Nutrient and Health ResponsesUniversity of PittsburghNot applicableRecruitingCardiometabolic Health20United Statesclinicaltrials.gov
August 6, 2025NCT07107971Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich PlaquesAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not applicableRecruitingCoronary Artery Disease, Atheroscleroses, Cardiovascular Disease, Vulnerable Coronary Plaques, Vulnerable Plaque...400Netherlandsclinicaltrials.gov
August 5, 2025NCT07104487[18F]AlF-NOTA-octreotide PET/MRI in Carotid Artery DiseaseUniversitaire Ziekenhuizen KU LeuvenPhase 2RecruitingStroke (CVA) or TIA, Carotid Artery Plaque, Atherosclerosis Cardiovascular Disease, Carotid Arteriosclerosis24Belgiumclinicaltrials.gov

Sponsors posting most

SponsorNew trialsLatest
Novartis Pharmaceuticals9April 22, 2026
Sanofi4October 30, 2026
AstraZeneca4June 2, 2025
Eli Lilly and Company3August 25, 2026
Novo Nordisk A/S3September 8, 2025
Washington University School of Medicine2November 4, 2026
Assiut University2August 19, 2026
Beijing Inno Medicine Co., Ltd.2April 9, 2026
Liverpool John Moores University2March 16, 2026
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)2March 3, 2026
Assistance Publique - Hôpitaux de Paris2February 23, 2026
Université Catholique de Louvain2February 3, 2026
Brigham and Women's Hospital2January 5, 2026
University Hospital, Akershus2December 24, 2025
University of Sao Paulo2December 17, 2025
Nantes University Hospital2December 4, 2025
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2October 6, 2025
University of Florida2March 3, 2025
Sir Run Run Shaw Hospital1November 5, 2026
NYU Langone Health1November 4, 2026

By phase

PhaseNew trialsLatest
Observational59November 4, 2026
Not applicable39November 5, 2026
Phase 213September 24, 2026
Phase 311September 2, 2026
Phase 49September 24, 2026
Early phase 13September 2, 2026
Phase 13June 2, 2026
Phase 1/22March 25, 2026

By country

CountryNew trialsLatest
United States33November 4, 2026
China23November 5, 2026
Spain14October 29, 2026
Netherlands14October 29, 2026
France12August 14, 2026
United Kingdom11November 3, 2026
Italy9October 30, 2026
Australia8May 29, 2026
Brazil8December 17, 2025
Japan7August 25, 2026
Hungary7August 3, 2026
South Korea7July 22, 2026
Germany7November 19, 2025
Puerto Rico6August 25, 2026
Czechia6May 29, 2026
Canada6April 9, 2026
Argentina5August 25, 2026
Turkey (Türkiye)5March 3, 2026
Belgium5February 3, 2026
Greece5September 12, 2025
Taiwan5September 5, 2025
Mexico4October 2, 2026
Austria4September 30, 2026
Sweden4May 7, 2026
India4September 8, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.